Upper limb function after botulinum toxin A treatment in cerebral palsy: Two years follow-up of six cases
暂无分享,去创建一个
Ilona Autti-Rämö | I. Autti-Rämö | M. Koivikko | H. Sätilä | Heli Sätilä | Anne Kotamäki | Matti Koivikko | Anne Kotamäki
[1] M. Wallen,et al. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial. , 2004, Archives of physical medicine and rehabilitation.
[2] G. Molenaers,et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. , 2000, Gait & posture.
[3] J. Dolly,et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Graham. Botulinum toxin A in cerebral palsy: functional outcomes. , 2000, The Journal of pediatrics.
[5] J B Carlin,et al. Reliability of the Melbourne assessment of unilateral upper limb function. , 2001, Developmental medicine and child neurology.
[6] L. Arens,et al. Botulinum Toxin A in the Hemiplegic Upper Limb: A Double‐blind Trial , 1997, Developmental medicine and child neurology.
[7] R. Calderón-González,et al. Botulinum toxin A in management of cerebral palsy. , 1994, Pediatric neurology.
[8] Richard W. Bohannon,et al. Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.
[9] I. Autti-Rämö,et al. Botulinum Toxin Injection as an Adjunct when Planning Hand Surgery in Children with Spastic Hemiplegia , 2000, Neuropediatrics.
[10] A. Eliasson,et al. Hand function in children with cerebral palsy after upper‐limb tendon transfer and muscle release , 1998, Developmental medicine and child neurology.
[11] F. Heinen,et al. Clinical impact of antibody formation to botulinum toxin A in children , 2004, Annals of neurology.
[12] M. Johnston,et al. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. , 2000, American journal of physical medicine & rehabilitation.
[13] S. Page,et al. Modified constraint-induced therapy and botulinum toxin A: a promising combination. , 2003, American journal of physical medicine & rehabilitation.
[14] A. Eliasson,et al. Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adapted model. , 2005, Developmental medicine and child neurology.
[15] H. Graham,et al. Botulinum toxin A in the hemiplegia upper limb: a double‐blind trial , 1997 .
[16] C. Pehoski,et al. Hand Function in the Child: Foundations for Remediation , 1994 .
[17] P. Mirrett,et al. Use of the Goal Attainment Scale in the treatment and ongoing evaluation of neurologically handicapped children. , 1978, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.
[18] Stephen M. Haley,et al. Pediatric evaluation of disability inventory (PEDI) : development, standardization and administration manual , 1998 .
[19] Gerry E Conti,et al. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. , 2003, Archives of physical medicine and rehabilitation.
[20] D Fehlings,et al. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. , 2000, The Journal of pediatrics.
[21] L. A. Koman,et al. Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.
[22] F. Gwathmey,et al. A dynamic approach to the thumb-in palm deformity in cerebral palsy. , 1981, The Journal of bone and joint surgery. American volume.
[23] R. Chan,et al. Effect of Botulinum Toxin Type A on Cerebral Palsy with Upper Limb Spasticity , 2003, American journal of physical medicine & rehabilitation.